SCHEMBL2743367

SCHEMBL2743367

O/N=C/c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.49
MAPT P10636 4/20 0.49
RAB9A P51151 4/20 0.49
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 2/20 0.49
GFER P55789 2/20 0.46
NPC1 O15118 3/20 0.46
MITF O75030 1/20 0.46
GAA P10253 1/20 0.46
CASP3 P42574 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
EPHX2 P34913 1/20 0.43
PIM1 P11309 1/20 0.42
PIM2 Q9P1W9 1/20 0.42
GCGR P47871 1/20 0.42
MAPK1 P28482 2/20 0.42
KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2166803 1.00 KMT2A (0.49) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL2166800 1.00 KMT2A (0.49) KMT2AMAPTRAB9AALDH1A1MEN1
Hydrochloric Acid SCHEMBL28403578 0.98 KMT2A (0.47) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL10663187 0.83 ALDH1A1 (0.49) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL10663191 0.83 ALDH1A1 (0.49) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL18288121 0.82 KMT2A (0.44) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL24017029 0.80 MEN1 (0.43) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL416723 0.80 MAOB (0.47) KMT2AMAPTRAB9AMEN1NPC1
SCHEMBL21129094 0.80 MEN1 (0.43) KMT2AMAPTRAB9AALDH1A1MEN1
SCHEMBL8909991 0.80 MAOB (0.47) KMT2AMAPTRAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697979-B Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2025-06-24 CN disclosed
CN-115697979-A Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2023-02-03 CN disclosed
US-11001594-B2 Heterocyclic modulators of HIF activity for treatment of disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-05-11 US disclosed
US-11001594-B2 Heterocyclic modulators of HIF activity for treatment of disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-05-11 US disclosed
WO-2020040343-A1 ISOXAZOLE DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2020-02-27 WO disclosed
US-20190270753-A1 HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE UNIV TEXAS (US) 2019-09-05 US disclosed
US-20190270753-A1 HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE UNIV TEXAS (US) 2019-09-05 US disclosed
US-10208059-B2 Heterocyclic modulators of HIF activity for treatment of disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-02-19 US disclosed
US-10208059-B2 Heterocyclic modulators of HIF activity for treatment of disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-02-19 US disclosed
US-10174033-B2 N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2019-01-08 US disclosed
WO-2014031936-A2 HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE JONES PHILIP (US) 2014-02-27 WO disclosed
EP-2617715-A1 GLYCINE TRANSPORTER INHIBITOR TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-07-24 EP disclosed
US-20130184460-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-07-18 US disclosed
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2013-02-21 US disclosed
EP-2511283-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-10-17 EP disclosed
US-20120190543-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2012-07-26 US disclosed
US-20120172218-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2012-07-05 US disclosed
US-20120122805-A1 PESTICIDAL COMPOSITIONS DOW AGROSCIENCES LLC (US) 2012-05-17 US disclosed
US-8178658-B2 Insecticide (against arthropods), nematocide; use against pesticide-resistant pests; use on plants and animals; Compounds are tetrahydropyrans substituted with an aryl-heteroaryl-aryl-containing group DOW AGROSCIENCES, LLC (US) 2012-05-15 US disclosed
US-20090209476-A1 Insecticide (against arthropods), nematocide; use against pesticide-resistant pests; use on plants and animals; Compounds are tetrahydropyrans substituted with an aryl-heteroaryl-aryl-containing group DOW AGROSCIENCES LLC (US) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209476-A1 Insecticide (against arthropods), nematocide; use against pesticide-resistant pests; use on plants and animals; Compounds are tetrahydropyrans substituted with an aryl-heteroaryl-aryl-containing group DDT, ACHE, NANP KMT2A 2528/4885MAPT 2297/4885RAB9A 371/4885
US-20120172218-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, PTMS KMT2A 1970/4885MAPT 3378/4885RAB9A 848/4885
US-20130184460-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC1A2, SLC18A2, SLC6A1 KMT2A 3110/4885MAPT 256/4885RAB9A 1016/4885
US-20120190543-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, AADAC KMT2A 390/4885MAPT 3486/4885RAB9A 769/4885
US-20190270753-A1 HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE HIF1AN, HIF1A, EGLN3 KMT2A 1042/4885MAPT 4777/4885RAB9A 3578/4885
US-20120122805-A1 PESTICIDAL COMPOSITIONS ACHE, DDT, PTMS KMT2A 1970/4885MAPT 3378/4885RAB9A 848/4885
US-10208059-B2 Heterocyclic modulators of HIF activity for treatment of disease HIF1AN, HIF1A, EGLN3 KMT2A 1042/4885MAPT 4777/4885RAB9A 3578/4885
US-10174033-B2 N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof ADORA2A, ADORA3, ADORA1 KMT2A 373/4885MAPT 117/4885RAB9A 846/4885
US-11001594-B2 Heterocyclic modulators of HIF activity for treatment of disease HIF1AN, HIF1A, EGLN3 KMT2A 1042/4885MAPT 4777/4885RAB9A 3578/4885
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF ADORA2A, ADORA3, ADORA1 KMT2A 373/4885MAPT 117/4885RAB9A 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.